Internal Medicine, Pulmonary Disease · Baton Rouge, LA
NPI
1346277746
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7373 Perkins Rd
Baton Rouge, LA, 70808
Phone (225) 769-4044
Groups this clinician bills Medicare through
Medicare paid, 2024
$172K
4,830 services
Medicare patients, 2024
640
Average age 75
Drug cost, 2024
$2.1M
5,138 prescriptions
Company payments, 2025
$29.43
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael P McCarthy was code 99214 (office e&m - established), 841 times for 439 patients. In total Michael P McCarthy billed 4,830 services in 88 codes, and Medicare paid $172K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 841 | 439 | $85.96 | $72K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 815 | 450 | $11.63 | $9,479 |
| 94010 Pulmonary Function Testing | Office | 227 | 207 | $18.33 | $4,160 |
| 94729 Pulmonary Function Testing | Office | 214 | 199 | $38.24 | $8,184 |
| 94727 Pulmonary Function Testing | Office | 214 | 199 | $29.88 | $6,394 |
| 99213 Office E&M - Established | Office | 154 | 126 | $56.02 | $8,626 |
| 99204 Office E&M - New | Office | 143 | 143 | $113.21 | $16K |
| 36415 Venipuncture Blood Collection | Office | 95 | 60 | $8.65 | $822 |
| 85025 Blood Count | Office | 56 | 39 | $7.61 | $426 |
| 80053 Clinical Chemistry | Office | 48 | 33 | $10.35 | $497 |
| 99406 Behavioral Health Services | Office | 31 | 29 | $13.57 | $421 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 29 | 29 | $25.91 | $751 |
| 94664 E&M - Miscellaneous | Office | 26 | 26 | $11.49 | $299 |
| 80061 Clinical Chemistry | Office | 25 | 20 | $13.12 | $328 |
| G0008 Administration of influenza virus vaccine | Office | 23 | 23 | $29.40 | $676 |
By year: 2022 $187K for 4,460 services; 2023 $176K for 4,237 services; 2024 $172K for 4,830 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 95 | 60 | $8.65 | $822 |
| 85025 Blood Count | 56 | 39 | $7.61 | $426 |
| 80053 Clinical Chemistry | 48 | 33 | $10.35 | $497 |
| 80061 Clinical Chemistry | 25 | 20 | $13.12 | $328 |
| 80048 Clinical Chemistry | 19 | 15 | $8.29 | $158 |
| 85652 Clinical Chemistry | 13 | 11 | $2.65 | $34.45 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael P McCarthy prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,323 prescriptions and refills. In total Michael P McCarthy wrote 5,138 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,323 | 1,842 | 271 | $1.2M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 512 | 623 | 190 | $19K |
| Prednisone Generic | 405 | 447 | 193 | $1,358 |
| Breo Ellipta Fluticasone/Vilanterol | 279 | 394 | 54 | $148K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 194 | 268 | 39 | $124K |
| Ventolin Hfa Albuterol Sulfate | 147 | 176 | 56 | $11K |
| Symbicort Budesonide/Formoterol Fumarate | 113 | 159 | 26 | $36K |
| Fluticasone Propionate Generic | 104 | 196 | 31 | $1,174 |
| Azithromycin Generic | 101 | 150 | 34 | $1,207 |
| Pantoprazole Sodium Generic | 99 | 173 | 24 | $857 |
| Montelukast Sodium Generic | 95 | 221 | 25 | $1,232 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 83 | 114 | 21 | $12K |
| Atorvastatin Calcium Generic | 79 | 221 | 20 | $538 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 67 | 125 | 25 | $13K |
| Spiriva Respimat Tiotropium Bromide | 62 | 125 | 18 | $62K |
Brand drugs: 2,829 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael P McCarthy $29.43 ($29.43 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $29.43.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 2 | $29.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.